Academic Journal

Increased platelet reactivity and platelet–leukocyte aggregation after elective coronary bypass surgery.

التفاصيل البيبلوغرافية
العنوان: Increased platelet reactivity and platelet–leukocyte aggregation after elective coronary bypass surgery.
المؤلفون: Ivert, Torbjörn, Dalén, Magnus, Ander, Charlotte, Stålesen, Ragnhild, Lordkipanidzé, Marie, Hjemdahl, Paul
المصدر: Platelets; 2019, Vol. 30 Issue 8, p975-981, 7p
مصطلحات موضوعية: CORONARY artery bypass, LEUKOCYTE count, BLOOD platelets, PLATELET function tests, BLOOD platelet activation, ASPIRIN
مستخلص: Inflammatory mechanisms are activated, and thrombotic complications occur during the initial months after coronary artery bypass grafting (CABG). Therefore, changes over time of platelet activation and platelet–leukocyte interactions after CABG are of interest. Whole-blood flow cytometry was performed before, and 4–6 days, one month, and three months after elective CABG in 54 men with stable coronary artery disease treated with acetylsalicylic acid (ASA). Single platelets and platelet–leukocyte aggregates (PLAs) among monocytes (P-Mon), neutrophils (P-Neu), and lymphocytes (P-Lym) were studied without and with stimulation by submaximal concentrations of ADP, thrombin, and the thromboxane analog U46619. White blood cell counts were increased during the initial postoperative course, and platelet counts were increased after one month. Platelet P-selectin expression was significantly enhanced at one month when stimulated by thrombin and U46619 and at three months with ADP and thrombin. All PLAs subtypes were increased at one month without stimulation in vitro. P-Mon and P-Neu stimulated by ADP, thrombin, or U46619 were significantly increased one month after the operation but decreased compared to baseline at three months. Agonist stimulated P-Lyms were increased at one month and remained increased at three months after ADP stimulation. There was significant platelet activation and formation of PLAs unstimulated and after agonist stimulation by ADP, thrombin, and a thromboxane analog after CABG in patients with stable coronary artery disease irrespective of ASA treatment. Changes observed up to three months after CABG support further studies of the clinical implications of protracted increases in platelet activation and platelet–leukocyte interactions. [ABSTRACT FROM AUTHOR]
Copyright of Platelets is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:09537104
DOI:10.1080/09537104.2018.1542122